SECURITIES AND EXCHANGE COMMISSION 
				 WASHINGTON, D.C.  20549 
 
					---------------- 
 
					    FORM 10-Q 
 
	[ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF 
			THE SECURITIES EXCHANGE ACT OF 1934 
			FOR THE PERIOD ENDED JUNE 30, 1997 
 
					      OR 
 
	[   ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) 
		   OF THE SECURITIES EXCHANGE ACT OF 1934 
		     FOR THE TRANSITION PERIOD FROM     TO  
 
					---------------- 
 
			    Commission file number 0-18160 
 
				       4HEALTH, INC. 
	  (Exact name of registrant as specified in its charter) 
 
					---------------- 
 
		Utah                       87-0468225 
  (State of incorporation)   (I.R.S. Employer Identification No.) 
 
				  5485 Conestoga Court 
			      Boulder, Colorado  80301 
		(Address of principal executive offices) 
 
		  Registrant's telephone number:  (303) 546-6306 
 
					---------------- 
 
Indicate by check mark whether the registrant (1) has  
filed all reports required to be filed by Section 13 or  
15(d) of the Securities Exchange Act of 1934 during the  
preceding 12 months (or for such shorter period that  
the registrant was required to file such reports),  
and (2) has been subject to such filing requirements  
for the past 90 days.  Yes:     X        No: 
 
The number of shares of the registrant's Common Stock,  
par value $.01 per share, outstanding as of June 30,  
1997 was 11,405,920. 
 
 
 
 
4Health, Inc. 
Index to Form 10-Q 
<TABLE> 
<CAPTION> 
<S>											    <C> 
PART I.  FINANCIAL INFORMATION			              Page 
Item 1.  Financial Statements: 
	Condensed Balance Sheets as of June 30, 1997  
		and December 31, 1996                              3 
	Condensed Statement of Operations for Three and 
		Six Months Ended June 30, 1997 and 1996            4 
	Condensed Statements of Cash Flows for Six  
		Months Ended June 30, 1997 and 1996                5 
	Notes to Condensed Financial Statements                 6 
Item 2. Management's Discussion and Analysis of  
	Financial Condition and Results of Operations           7 
PART II.  OTHER INFORMATION 
Item 1. Legal Proceedings					          10 
Item 4. Submission of Matters to a Vote of Security Holders 10 
Item 5. Other Information                                   10 
Item 6. Exhibits and Reports on Form 8-K                    11 
	   SIGNATURES									16 
</TABLE> 
 
	This Quarterly Report on Form 10-Q includes "forward-looking 
statements" within the meaning of Section 27A of the Securities 
Act of 1933, as amended (the "Securities Act") and Section 21E of 
the Securities Exchange Act of 1934, as amended (the "Exchange 
Act").  All statements other than statements of historical facts 
included in this Quarterly Report, including, without limitation, 
those regarding the Company's financial position, business, 
marketing and product introduction and development plans and 
objectives of management for future operations, are forward-
looking statements.  Although the Company believes that the 
expectations reflected in such forward-looking statements are 
reasonable, it can give no assurance that such expectations will 
prove to have been correct.  Important factors that could cause 
actual results to differ materially from the Company's 
expectations ("Cautionary Statements") are disclosed under "Risks 
Related to the Business of 4Health" and elsewhere in the 
Company's Annual Report on Form 10-K dated March 27, 1997 and in 
"Management's Discussion and Analysis of Financial Condition and 
Results of Operations" and elsewhere in the Annual Report.  All 
subsequent written and oral forward-looking statements 
attributable to the Company or persons acting on behalf of the 
Company, are expressly qualified in their entirety by the 
Cautionary Statements.  
 
 
 
 
PART I. 	FINANCIAL INFORMATION 
Item 1.  	Financial Statements 
 
					4Health, Inc. 
				Condensed Balance Sheets 
					(Unaudited) 
<TABLE> 
<CAPTION> 
 
								 June 30,	   December 31, 
								   1997		  1996 
								    <C>		   <C> 
ASSETS 
CURRENT ASSETS 
Cash and cash equivalents	    		$  318,656   $ 1,086,168 
Accounts receivable, net				   986,375     1,105,207 
Inventories						 1,717,320	2,534,881 
Deferred tax asset					   336,509	  313,872 
Prepaid expenses					   698,923 	  171,138 
Notes receivable					   178,684	  265,820 
  Total current assets				 4,236,467	5,477,086 
 
PROPERTY AND EQUIPMENT, NET			 2,543,286	2,559,629 
PREPAID EXPENSES					   700,000	        0 
OTHER ASSETS, NET					 1,068,444	1,136,531 
NOTES RECEIVABLE					    97,185	  116,308 
  Total assets						$8,645,382    $9,289,553 
								==========    ========== 
LIABILITIES AND STOCKHOLDERS' EQUITY 
CURRENT LIABILITIES 
Accounts payable					$1,483,691	 $484,079 
Accrued liabilities					   579,701	  878,025 
Taxes payable						    49,385	  113,833 
Notes payable						    28,268	   20,555 
Capital leases							1,389	    3,733 
  Total current liabilities			 2,142,434	1,500,225 
 
DEFERRED TAXES						    33,271	  152,112 
NOTES PAYABLE						 1,312,753	1,275,716 
 
STOCKHOLDERS' EQUITY 
Common stock						   114,059	  113,695 
Additional paid in capital-common stock	 8,357,436     8,227,752 
Additional paid in capital-common warrants  86,507		   0 
Treasury stock						   (50,000)	  (50,000) 
Accumulated deficit					(3,351,078)   (1,929,947) 
  Total stockholders' equity		      5,156,924	6,361,500 
Total liabilities & stockholders' equity$8,645,382   $ 9,289,553 
								==========   ============ 
</TABLE> 
See notes to condensed financial statements 
					4Health, Inc. 
			Condensed Statements of  Operations 
					(Unaudited) 
 
<TABLE> 
<CAPTION> 
				    Three Months 			Six Months 
		             Ended June 30, 		   Ended June 30, 
				   1997	   1996	   	 1997	  1996 
				   <C>	   <C>  	      <C>	        <C> 
Net Sales         $3,424,393  $8,007,026  $7,220,347 $11,480,425 
Cost of goods sold 1,832,400   3,238,201   3,547,728   4,495,657 
Gross margin       1,591,993   4,768,825   3,672,619   6,984,768 
 
Operating Expenses 
  Sales              596,265     899,335   1,137,853   1,427,163 
  Marketing        1,116,379   3,097,806   2,302,717   4,095,506 
  Research and  
    development      124,604      94,213     298,406     153,700 
  General and  
    administrative   731,343     650,800   1,500,427   1,247,475 
 
Total operating  
  expenses         2,568,591   4,742,154   5,239,403   6,923,844 
 
Net income from  
  operations        (976,598)     26,671  (1,566,784)     60,924 
 
Other income  
  (expense)	      (18,042)    (13,823)      4,275     (24,252) 
 
Net income (loss)  
  before income  
  taxes             (994,640)     12,848  (1,562,509)     36,672 
 
Income tax benefit 
  (provision)		       0      86,801     141,378      74,639 
 
NET INCOME (LOSS)   $(994,640)   $99,649 $(1,421,131)   $111,311 
				==========   ========  ==========   ======== 
Net income (loss) 
  per common share     (0.087)      0.012     (0.125)       .013 
				==========    =======  ==========  ========= 
Weighted average 
  shares  
  outstanding      11,388,326   8,633,825  11,380,483 8,674,276 
			    ==========   =========  ========== ========= 
</TABLE> 
 
See notes to condensed financial statements. 
 
					4Health, Inc. 
			Condensed Statements of Cash Flows 
					(Unaudited) 
<TABLE> 
<CAPTION> 
							 Six Months Ended June 30, 
							     1997         1996     
								 <C>		   <C> 
CASH FLOWS FROM OPERATING ACTIVITIES 
Net income (loss)	 			$(1,421,131)   $  111,311 
Adjustments to reconcile net income 
 (loss) to net cash provided by  
  operating activities: 
  Depreciation and amortization        168,894        90,413 
  Bad debt expense					   263		    0 
  Loss on disposal of assets			 3,683		4,501 
  Issuance of Warrants				86,507		    0 
(Increase) decrease in: 
  Accounts receivable			    118,570	(2,757,494) 
  Inventory					    817,561	  (822,794) 
  Prepaid expenses and other		 (1,204,009)	  (336,412) 
  Deferred income tax assets		    (22,637)	   (32,604) 
(Increase) decrease in: 
  Accounts payable				    999,612	 2,916,951 
  Accrued interest payable			     0	   (22,399) 
  Accrued liabilities			   (298,325)	   486,429 
  Taxes payable				    (64,448)	   (14,416) 
  Deferred income tax liability	   (118,841)	    17,992 
Net cash (used in) from operating  
  activities					   (934,303)	  (358,521) 
CASH FLOWS FROM INVESTING ACTIVITIES 
  Purchase of fixed assets            (111,923)     (267,266) 
  Proceeds from note receivable        106,258             0 
Net cash from (used in) investing 
  activities                            (5,665)     (267,266) 
CASH FLOWS FROM FINANCING ACTIVITIES 
  Proceeds from common stock           130,049             0 
  Borrowings on long-term debt       1,350,000             0 
  Repayments on borrowings          (1,305,250)      (71,198) 
  Repayments on capital leases          (2,344)       (3,210) 
Net cash used in financing activities  172,455       (74,408) 
 
NET (DECREASE) INCREASE IN CASH       (767,512)     (700,195) 
CASH AND CASH EQUIVALENTS, at 
  beginning of period                1,086,168        919,935 
CASH AND CASH EQUIVALENTS, at  
  end of period                     $  318,656     $  219,741 
							 ==========     ========== 
</TABLE> 
See notes to condensed financial statements. 
 
					4Health, Inc. 
		Notes to Condensed Financial Statements 
				    June 30, 1997 
					(Unaudited) 
 
Note 1:	 
Basis of Presentation 
 
	The accompanying unaudited condensed financial statements 
have been prepared in accordance with generally accepted 
accounting principles for interim financial information and with 
the instructions to Form 10-Q and Article 10 of Regulation S-X.  
Accordingly, they do not include all of the information and 
footnotes required by generally accepted accounting principles 
for complete financial statements.  In the opinion of management, 
all adjustments (consisting of normal recurring accruals) 
considered necessary for a fair presentation have been included.  
Operating results for the six month period ended June 30, 1997 
are not necessarily indicative of the results that may be 
expected for the year ended December 31, 1997.  For further 
information, refer to the consolidated financial statements and 
footnotes thereto included in the Form 10-K dated March 31, 1997 
and the Company's Proxy Statement dated April 25, 1997. 
 
Note 2:	 
Certain Sales Transactions 
 
	In February 1997, the Company entered into a negotiated 
settlement with General Nutrition Corporation, Inc. ("GNC") to 
settle all pending litigation between the two parties.  The terms 
of the settlement include the Company supplying GNC with certain 
4Health products free of charge and taking back certain other 
4Health products.  The execution of this settlement agreement was 
completed during the first and second quarters of 1997.   
 
	On February 25, 1997, 4Health entered into a barter 
agreement with Active Media Services, Inc.  Under the terms of 
the agreement, the Company sold to Active Media Services, Inc. 
certain inventory with a cost of $780,308 for which the Company 
received $2,300,000 in barter credits.  These barter credits can 
be used in lieu of cash to purchase goods and services available 
through Active Media Services, Inc.  4Health intends to use these 
barter credits for advertising, printing, travel, and other 
normal operating expenditures.  This transaction was recorded at 
the cost of the product sold to Active Media Services, Inc. 
($758,308) and the unused portion of the barter credits is 
reflected in the balance sheet as a prepaid expense.  As of June 
30, 1997, none of the barter credits had been used.  Product 
costing $424,149 was shipped to Active Media Services, Inc. 
during the first quarter with the balance of $334,159 shipped in 
the second quarter 1997. 
Item 2.  Management's Discussion and Analysis of Financial 
Condition and Results of Operations 
 
	See the disclosure regarding forward looking statements 
above. 
 
Results of Operations 
 
Comparison of Second Quarter 1997 to 1996 
 
Net sales for the three months ended June 30, 1997 decreased to 
$3.4 million from $8 million or 57 % compared to the same period 
a year ago.  Net sales during the quarter ended June 30, 1996 
included a large sale to a major customer in the amount of 
approximately $5 million.  Net sales during the quarter ended 
June 30, 1997 included a sale of $334 thousand to Active Media 
Services, Inc., a barter company.  Net sales related to core 
business activities decreased by $.9 million or 24% to $2.7 
million in the second quarter of 1997 from $3.6 million in the 
second quarter of 1996.  Net sales in the Nature's Secret 
division decreased by $1.3 million while sales in the other 
divisions of the company increased by $411 thousand, $335 
thousand of which can be attributed to the Mass Market division.  
Management attributes the decrease in Nature's Secret sales to 
increased competition and ineffective marketing and sales 
promotions. 
 
The gross margin percentage for the quarter ended June 30, 1997 
decreased by 13% to 46% down from 59% for the same period in 
1996.  Management attributes 10% of the 13% margin percent 
decrease to a sale to Active Media Services, Inc. of $334 
thousand which was recorded at the cost of the product and to an 
inventory write-off in the amount of $114 thousand, the majority 
of which was related to packaging which became obsolete due to 
graphics changes.  During the second quarter of 1997, the core 
business gross margin percentage decreased by 3% to 56% from 59% 
compared to the same period in 1996, due to a shift in sales to 
products with lower profit margins and increased discounting.  
The gross margin of $1.6 million for the quarter ended June 30, 
1997 represented a $3.2 million or 67% decrease from a gross 
margin of $4.8 million compared to the same period in 1996.  The 
majority of this difference was due to a combination of $3 
million of gross margin related to a large sale to a major 
customer in 1996, a decrease in normal gross margin to the same 
major customer of $173 thousand of gross margin, decreased 
product sales to other customers in 1997 which caused a margin 
reduction of $436 thousand, and an inventory write off of $114 
thousand in 1997.     
 
Marketing expenses decreased $2 million or 64% from $3.1 million 
to $1.1 million in the second quarter ended June 30, 1997 as 
compared to the same period in 1996 due mainly to a reduction in 
media advertising costs related to a large sale to a major 
customer in 1996.  Sales costs decreased $303 thousand or 34% 
from $899 thousand to $596 thousand for the quarter ended June 
30, 1997, as compared to the same quarter of 1996, due mainly to 
decreased personnel costs and decreased special sales promotional 
costs which again related to a large sale to a major customer in 
1996.  These and other expense reductions were the result of cost 
cutting measures implemented by management.  Research and 
development costs increased by $30 thousand from $94 thousand to 
$124 thousand in the quarter ended June 30, 1997, as compared to 
the same quarter in 1996 due to new clinical studies personnel 
and product trial costs.  General and administrative expenses 
increased $80 thousand or 12% to $731 thousand in the second 
quarter ended June 30, 1997 from $651 thousand during the same 
period in 1996 mainly due to new costs related to being a public 
company, such as investment banker fees, SEC reporting, transfer 
agent fees and investor relations costs.  In total, operating 
costs decreased $2.1 million or 46% from $4.7 million to $2.6 
million during the quarter ended June 30, 1997 as compared to the 
same quarter in 1996. 
 
Comparison of Year-to-Date 1997 to 1996 
 
Net sales for the six months ended June 30, 1997 decreased by 
$4.3 million or 37% to $7.2 million from $11.5 million compared 
to the same period a year ago.  The decrease in net sales for the 
six months ended June 30, 1997 compared to the same period in 
1996 is due in part to a drop in sales to a major customer of 
$5.8 million which included a large sale in the amount of $5 
million included in 1996 net sales.  The six months ending June 
30, 1997 included a $758 thousand sale to Active Media Services, 
Inc., a barter company.  Net sales related to core business 
activities during the six months ended June 30, 1997 decreased by 
$1.2 million or 17% to $5.9 million from $7.1 million during the 
same period in 1996.  For the six months ended June 30, 1997 
compared to the same period in 1996, net sales in the Nature's 
Secret division decreased by $2.1 million or 32% from $6.5 
million to $4.4 million, while the Mass Market division increased 
by $873 thousand.  Management attributes the decrease in Nature's 
Secret to increased competition and ineffective marketing and 
sales promotions. 
 
The gross margin percent for the six months ended June 30, 1997 
decreased by 10% to 51% from 61% during the same period in 1996.  
Management attributes 7% of the difference to a sale to Active 
Media Services, Inc. of $758 thousand which was recorded at the 
cost of the product sold and to an inventory write-off in the 
amount of $114 thousand, the majority of which was related to 
packaging which became obsolete due to graphics changes.  For the 
six months ended June 30, 1997, the core business gross margin 
percentage decreased by 3% to 58% from 61% for the same period in 
1996 due to a shift in sales to products with lower profit 
margins and increased discounting.  The gross profit for the six 
months ended June 30, 1997 decreased by $3.3 million or 47% to 
$3.7 million from $7 million during the same period in 1996.  
Management attributes the majority of this difference to a large 
sale to a major customer in 1996 with a gross profit of $3 
million, $456 thousand in decreased margin to that same major 
customer exclusive of the large sale, a drop in product sales to 
other customers resulting in a decreased margin of $472 thousand 
and a write off of inventory of $114 thousand in 1997.     
 
For the six months ended June 30, 1997, marketing expenses 
decreased $1.8 million or 44% to $2.3 million from $4.1 million 
in the same period in 1996 due mainly to a reduction in media 
advertising costs, which, as a percent of sales, was a 4% 
decrease. For the six months ended June 30, 1997, sales costs 
decreased $290 thousand or 20% to $1.1 million from $1.4 million 
in the same period in 1996 due to decreased personnel related 
costs and special sales promotional costs. Research and 
development costs increased $144 thousand from $154 thousand to 
$298 thousand for the six months ended June 30, 1997 as compared 
to the same period in 1996 due to new clinical studies personnel 
and product trial costs.  General and administrative expenses 
increased $253 thousand or 20% to $1.5 million for the six months 
ended June 30, 1997 as compared to $1.2 million in the same 
period in 1996, primarily due to new costs related to being a 
public company such as investment banker fees, SEC reporting, 
transfer agent fees and investor relations costs.  For the six 
months ended June 30, 1997, total operating costs decreased by 
$1.7 million or 24% to $5.2 million from $6.9 million in the same 
period in 1996. 
 
Interest income increased 42% to $35 thousand for the six months 
ended June 30, 1997 from $25 thousand during the same period in 
1996 due to a higher average balance of cash and cash equivalents 
invested in 1997 than in the same period in 1996. 
 
Liquidity and Capital Resources 
 
The Company's cash and cash equivalents position at June 30, 1997 
was $318 thousand as compared to $1.1 million on December 31, 
1996, a decrease of $767 thousand.  The decrease in cash and cash 
equivalents position was a result of these resources being used 
to fund ongoing operations.  The Company has a working capital 
ratio of  2.0 to 1. 
 
The company invests it's cash in an interest bearing money market 
account. 
 
Accounts receivable totaled $1.0 million at June 30, 1997 as 
compared to $1.1 million at December 31, 1996, a decrease of $118 
thousand or 11%.  The accounts receivable decrease was due 
primarily to the receipt of the final payment related to a large 
sale to a major customer in 1996.  
 
A decrease of $818 thousand or 32% in inventory valued at $1.7 
million at June 30, 1997 as compared to $2.5 million at December 
31, 1996 was due to a sale to Active Media Services, Inc. of $758 
thousand of product. 
 
Prepaid expenses increased by $1.2 million or 717% to $1.4 
million at June 30, 1997 from $171 thousand at December 31, 1996.  
The reasons for this increase were the expenditures related to 
the prepayment of advertising and promotion costs for the UnDo 
product, the expenses associated with the introduction of new 
products and packaging and the value of barter credits arising 
from the sale to Active Media Services, Inc., a barter company.  
 
Capital expenditures for the six months ended June 30, 1997 were 
$83 thousand as compared to $272 thousand for the same period in 
1996. 
 
Accounts payable and accrued liabilities increased to $2.1 
million at June 30, 1997 from $1.4 million as of December 31, 
1996, an increase of $701 thousand or 34 %.  The majority of the 
increase in accounts payable and accrued liabilities is 
attributable to new product materials, packaging and marketing 
costs and prepaid advertising and promotion costs related to the 
UnDo product. 
 
The deferred tax liability at June 30, 1997 was $33 thousand, a 
decrease of $119 thousand from $152 thousand at December 31, 1996 
which was the result of interim tax estimates by management. 
 
Additional paid in capital related to warrants as of June 30, 
1997 was $87 thousand as compared to $0 at December 31, 1996.  
These warrant costs relate to warrant certificates issued on 
April 15, 1997 in which warrants are to be exchanged for 
investment banking and consulting services. 
 
PART II.  OTHER INFORMATION 
 
Item 1.  Legal Proceedings 
 
	On July 10, 1997, 4Health, Inc. was served notice of a law 
suit filed against the company by the Richard's Group, Inc.  The 
action, Richard's Group, Inc. vs. 4Health, Inc. (97-05669-L), was 
filed in the District Courts of Dallas County, Texas on June 20, 
1997.  The action requests judgment be made by the Court against 
4Health, Inc. regarding outstanding fees in the amount of 
$61,839.92, interest, and legal expenses incurred by the 
plaintiff in this matter.  The action alleges that these fees 
were incurred by the Company for advertising services provided by 
the plaintiff.  On August 4, 1997, the Company answered the 
complaint denying all charges.  The Company does not believe a 
judgment against 4Health, Inc. in this case would have a negative 
material effect. 
 
Item 4. Submission of Matters to a Vote of Security Holders 
 
	On June 6, 1997, the Company held the 1997 Annual Meeting of 
Shareholders.  The total number of shares present, in person or 
by proxy, and entitled to vote at the meeting was 9,537,116.  The 
following proposals were submitted to shareholders for approval: 
 
1.	Approval of election of Steven B. Beckman as a director of 
the 4Health, Inc. Board of Directors and to serve a three year 
term. 
 
	For:		  9,560,318 
	Withhold:	     30,798 
 
2.	Appointment of Arthur Andersen LLP as auditors for the 
fiscal year ending December 31, 1997. 
 
	For:		   9,530,511 
	Against:	       4,053 
	Abstain:	       2,552 
 
Item 5.  Other Information 
 
	No other relevant matters occurred during the first quarter 
ended June 30, 1997. 
 
Item 6.  Exhibits and Reports on Form 8-K 
 
				   Exhibit Index 
 
Item 2. Plan of Acquisition, Reorganization, Liquidation, or 
Succession 
 
2.01		Agreement and Plan of Merger dated April 10, 1996, by 
and between 4health, Inc., and Surgical Technologies, Inc. as 
amended June 4, 1996.  Incorporated by Reference (4). 
 
2.02		Asset Purchase Agreement dated November 30, 1995, by 
and between Microtek Medical, Inc., and Surgical Technologies, 
Inc. Incorporated by Reference (3). 
 
2.03		Acquisition Agreement dated effective January 1, 1996, 
by and between Rex Industries Acquisition Corporation and Rex 
Industries, Inc.  Incorporated by Reference (3). 
 
Item 3.  Articles of Incorporation and Bylaws 
 
3.01		Articles of Incorporation of Surgical Subsidiary, Inc., 
a Utah Corporation now known as Surgical Technologies, Inc. 
Incorporated by Reference (6). 
 
3.02		Articles of Merger and related Plan of Merger.  
Incorporated by 
Reference (6). 
 
3.03		Bylaws.  Incorporated by Reference (6). 
 
3.04		Articles of Merger and related Plan of Merger. 
Incorporated by Reference (4). 
 
Item 4.  Instruments Defining the Rights of Security Holders 
 
4.01		Form of Warrant Agreement between 4Health, Inc. and 
Zions First National Bank with related form of Warrant. 
Incorporated by Reference (4). 
 
4.02		Form of Sale Restriction Agreement respecting 
shareholders of both Surgical Technologies, Inc., and 4Health, 
Inc. Incorporated by Reference (4). 
 
4.03		Form of Consent, Approval, and Irrevocable Proxy 
respecting certain Surgical stockholders with related schedule. 
Incorporated by Reference (4). 
 
4.04		Form of Consent, Approval, and Irrevocable Proxy 
respecting certain 4Health stockholders with related schedule.  
Incorporated by Reference (4). 
 
4.05		Specimen Common Stock Certificate. Incorporated by 
Reference (4). 
 
4.06		Specimen Warrant Certificate.  Incorporated by 
Reference (4). 
 
4.07		Warrant certificates between 4Health and Allen & 
Company Incorporated dated April 15, 1997.  Incorporated by 
Reference (8). 
 
Item 10.  Material Contracts 
 
10.01		Form of Directors' Options.  Incorporated by 
Reference (3).* 
 
10.02		Stock Option and Stock Award Plan. Incorporated by 
Reference (3).* 
 
10.03		1991 Directors' Stock Option Plan. Incorporated by 
Reference (3).* 
 
10.04		Directors' Stock Option Plan. Incorporated by 
Reference (5).* 
 
10.05		Technology Purchase Agreement between Ellis E. 
Williams, Professional Medical, Inc., and Surgical Technologies, 
Inc., dated February 4, 1993. Incorporated by Reference (6). 
 
10.06		Patent Cross-License Agreement between Utah 
Medical Products, Inc., and Professional Medical, Inc., dated 
February 9, 1993. Incorporated by Reference (7). 
 
10.07		Form of Promissory Note in the amount of 
$1,000,000 payable to First Interstate Bank, dated August 16, 
1994.  Incorporated by Reference (7). 
 
10.08		Deed of Trust Note and related Deed of Trust, 
Assignment of Rents, Security Agreement, and Fixture Filing, 
dated April 8, 1994, in the principal amount of $1,000,000 due 
Standard Insurance Company.  Incorporated by	Reference (6). 
 
10.09		Stock Purchase Agreement dated May 6, 1994, 
between Surgical Technologies, Inc., and Benitex, A.G. 
Incorporated by Reference (6). 
 
10.10		Real Estate Contract dated February 2, 1994, 
between Surgical Technologies, Inc. and Rex Crosland related to 
the facilities at 2801 South Decker Lake Lane, Salt Lake City, 
Utah. Incorporated by Reference (6). 
 
10.11		Asset Purchase Agreement between Milwaukee 
Acquisition Company, Insulation Distributors, Inc., and Surgical 
Technologies, Inc., effective September 30, 1993. Incorporated by 
Reference (6). 
 
10.12		All-Inclusive Promissory Note and related All-
Inclusive Trust Deed, relating to sale of building and property, 
dated March 31, 1995, in the principal amount of $981,375.32. 
Incorporated by Reference (7). 
 
10.13		1996 Long-Term Stock Incentive Plan. Incorporated 
by Reference (4). 
 
10.14		Form of $2.00 option granted to Surgical 
directors, officers, and employees with related schedule. 
Incorporated by Reference (4).* 
 
10.15		Form of Option granted to Todd B. Crosland. 
Incorporated by Reference (4).* 
 
10.16		Form of Option granted to Rockwell D. Schutjer.  
Incorporated by Reference (4).* 
 
10.17		Form of Proprietary Information, Inventions, and 
Non-Competition Agreement between 4Health and R. Lindsey Duncan.  
Incorporated by Reference (4). 
 
10.18		Form of Employment Agreement between the Surviving 
Corporation and Rockwell D. Schutjer.  Incorporated by 
Reference (4).* 
 
10.19		Deed of Trust Note and related Deed of Trust, 
Assignment of Rents, Security Agreement, and Fixture Filing, 
dated February 20, 1997, in the principal amount of $1,350,000 
due Standard Insurance Company.  Incorporated by 
Reference (2). 
 
Item 20.  Other Documents or Statements to Security Holders 
 
20.01		Notice of change of transfer and warrant agent. 
Incorporated by Reference (1). 
 
Item 27.  Financial Data Schedule 
 
27.01		Financial Data Schedule.  This Filing. 
 
(1)	Incorporated by reference from 4Health's report on Form 10-Q 
for the quarter ended March 31, 1997. 
 
(2)	Incorporated by reference from 4Health's report on Form 10-K 
for the year ended December 31, 1996. 
 
(3)	Incorporated by reference from Surgical's registration 
statement on Form S-1 filed with the Commission, SEC file number 
33-31863. 
 
(4)	Incorporate by reference from Surgical's registration 
statement on Form S-4 filed with the Commission, SEC file number 
33-03243. 
 
(5)	Incorporated by reference from Surgical's report on Form 10-
K for the year ended March 31, 1992. 
 
(6)	Incorporated by reference from Surgical's report on Form 10-
K for the year ended March 31, 1994. 
 
(7)	Incorporated by reference from Surgical's report on Form 10-
Q for the quarter ended December 31, 1995. 
 
(8)	Incorporated by reference from Schedule 13D filed with the 
Commission by Allen & Company Incorporated on April 18, 1997. 
 
*	Represents a management contract, compensatory plan, or 
arrangement required to be filed as an exhibit. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
					 Signatures  
 
	Pursuant to the requirements of the Securities Exchange Act 
of 1934, the registrant has duly caused this report to be signed 
on its behalf by the undersigned thereunto duly authorized. 
 
 
						4Health, Inc. 
 
Dated: August 12, 1997 
By: /s/ R. LINDSEY DUNCAN 
        R. Lindsey Duncan 
President and Chief Executive Officer 
 
Dated: August 12, 1997 
By: /s/ SCOTT W. LUSK 
        Scott W. Lusk 
Controller (Principal Accounting Officer)